Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 2, 1999, Pages 120-128

  Cheng, Yue ^a   Ng, Ho Keung ^a,d   Ding, Min ^b   Zhang, Shang Fu ^c   Pang, Jesse Chung Sean ^a   Lo, Kwok Wai ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b ANHUI PROVINCIAL HOSPITAL   (China)

^c SICHUAN UNIVERSITY   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Astrocytic tumor progression; Formalin fixed paraffin embedded tissue; Heterogeneity; Microdissection; Molecular analysis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; RECEPTOR PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CHILD; CHROMOSOME 10Q; CHROMOSOME 17P; CHROMOSOME 9P; CONTROLLED STUDY; DISSECTION; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; RECEPTOR GENE;

EID: 0032986688     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199902000-00002     Document Type: Article

References (39)

1. Burger PC, Scheithauer BW. Atlas of tumor pathology. Tumors of the central nervous system. 3rd series. Washington, D.C. Armed Forces Institute of Pathology, 1994;52-57
2. Burger PC, Kleihues P. Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies. Cancer 1989;63:2014-23
3. Wikstrand CJ, Grahmann FC, McComb RD, Bigner DD. Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies. J Neuropathol Exp Neurol 1985;44:229-41
4. Stavrou D, Keiditsch E, Schmidberger F, et al. Monoclonal antibodies against human astrocytomas and their reactivity pattern. J Neurol Sci 1987;80:205-20
5. Berkman RA, Clark WC, Saxena A, Robertson JT, Oldfield EH, Ali IU. Clonal composition of glioblastoma multiforme. J Neurosurg 1992;77:432-37
6. Leenstra S, Troost D, Westerveld A, Bosch DA, Hulsebos TJM. Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas. Cancer Res 1992;52: 1568-72
7. Biernat W, Aguzzi A, Sure U, Grant JW, Kleihues P, Hegi ME. Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J Neuropathol Exp Neurol 1995; 54:651-56
8. Kraus JA, Koopmann J, Kaskel P, et al. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995; 54:91-95
9. Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P, Ohgaki H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 1996;6:217-23
10. Reifenberger J, Ring GU, Gies U, et al. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neuropathol Exp Neurol 1996; 55:822-31
11. Bigner SH, Burger PC, Wong AJ, et al. Gene amplification in malignant human gliomas: Clinical and histopathologic aspects. J Neuropathol Exp Neurol 1988;47:191-205
12. Waha A, Baumann A, Wolf HK, et al. Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-a pathway in human astrocytic gliomas. J Neurosurg 1996;85:634-41
13. Schmidt EE, Ichimura K, Reifenberger G, Collins VP CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 1994;54:6321-24
14. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res 1995;55: 20-23
15. von Deimling A, Louis DN, von Ammon K, et al. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 1992;77:295-301
16. Rasheed BKA, Mclendon RE, Friedman HS, et al. Chromosome 10 deletion mapping in human gliomas: A common deletion region in 10q25. Oncogene 1995;10:2243-46
17. Ichimura K, Schmidt EE, Miyakawa A, Goike HM, Collins VP. Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignant grades. Genes Chromosomes Cancer 1998;22:9-15
18. Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene. MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15: 356-62
19. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-47
20. Mollenhauer J, Wiemann S, Scheurlen W, et al. DMBT1, a new member of the SRCR superfamily. on chromosome 10q25.3-26.1 is deleted in malignant brain tumors. Nat Genet 1997;17:32-40
21. Duerr EM, Rollbrocker B, Hayashi Y, et al. PTEN mutations in gliomas and glioneuronal tumors. Oncogene 1998;16:2259-64
22. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. 2nd ed. Springer-Verlag, 1993;11-30
23. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, 1989; 9.17-9.19
24. Tse JYM, Ng HK, Lau KM, Lo KW, Poon WS, Huang DP. Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas. Hum Pathol 1997;28:779-85
25. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-28
26. Hunter SB, Abbott K, Varma VA, Olson JJ, Barnett DW, James CD. Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue. J Neuropathol Exp Neurol 1995;54:57-64
27. Neubauer A, Neubauer B, He M, et al. Analysis of gene amplification in archival tissue by differential polymerase chain reaction. Oncogene 1992;7:1019-25
28. Ng HK, Lo SY, Huang DP, Poon WS. Paraffin section p53 protein immunohistochemistry in neuroectodermal tumors. Pathology 1994;26:1-5
29. Watanabe K, Sato K, Biernat W, et al. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res 1997;3:523-30
30. von Deimling A, von Ammon K, Schoenfeld DA, Wiestler OD, Seizinger BR, Louis DN. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993;3:19-26
31. van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF, Cairncross JG. p53 mutation, expression, and DNA ploidy in evolving gliomas: Evidence for two pathways of progression. J Natl Cancer Inst 1994;86:1011-17
32. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 1992;355:846-47
33. Louis DN, The p53 gene and protein in human brain tumors. J Neuropathol Exp Neurol 1994;53:11-21
34. Newcomb EW, Madonia WJ, Pisharody S, Lang FF, Koslow M, Miller DC. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol 1993;3: 229-35
35. Rubio MP, von Deimling A, Yandell DW, Wiestler OD, Gusella JF, Louis DN. Accumulation of wild type p53 protein in human astrocytomas. Cancer Res 1993;53:3465-67
36. Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakow PM, Gudkow AV. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature 1998; 391:295-98
37. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariabley associated with gene amplification. Proc Natl Acad Sci USA 1987;84:6899-6903
38. Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human glioma in vivo. Cancer Res 1991;51:2164-72
39. Diedrich U, Lucius J, Baron E, Behnke J, Pabst B, Zoll B. Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis. J Neurol 1995;242:683-88